RNL Bio had a challenging year in 2012 in my opinion. It was sued in U.S. court for stem cell fraud by Korean national patients living in the U.S. It had a legal tussle, still ongoing, with former partner Celltex over custody of Celltex’s banked patient stem cells. Well, it seems to me that 2013 …
RNL Bio charges for alleged stem cell smuggling raise larger questions Read More »
My blog’s Stem Cell Person of the Year 2012 yielded about 30 nominations and 16 finalists who were candidates in an online vote that is now complete. More than 4,600 votes were cast including about 1,000 in less than one day after the voting started. The online vote is but one factor in my decision on …
For the second year in a row (see awards 2011), Advanced Cell Technology (ACT; stock symbol ACTC) is my stem cell biotech of the year. Their trials for different forms of macular degeneration (here and here and here) are progressing well and as a stem cell scientist I really appreciate the fact they are publishing their …
Stem cell biotech of the year 2012: Advanced Cell Technology (ACTC) Read More »
Stem cell blogs make a big contribution to the stem cell world. Which is the best? It’s a tough choice. This year my pick is stemcellassays.com by Alexey Bersenev as 2012 Stem Cell Blog of the Year. You can also follow Alexey on Twitter here. Congrats to Alexey. Alexey’s blog consistently is outstanding in that it …
Stem cell blog of the year 2012: stemcellassays.com by Alexey Bersenev Read More »